世界の癌胎児性抗原（CEA）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1106 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、癌胎児性抗原（CEA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f）、用途別市場規模（大腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・癌胎児性抗原（CEA）の市場動向 ・企業の競争状況、市場シェア ・癌胎児性抗原（CEA）の種類別市場規模（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f） ・癌胎児性抗原（CEA）の用途別市場規模（大腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん、その他） ・癌胎児性抗原（CEA）の北米市場規模2016-2027（アメリカ、カナダ） ・癌胎児性抗原（CEA）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・癌胎児性抗原（CEA）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・癌胎児性抗原（CEA）の中南米市場規模2016-2027（メキシコ、ブラジル） ・癌胎児性抗原（CEA）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Diagnostics、Abbott Diagnostics、Quest Diagnostics） ・結論

Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.

Market Analysis and Insights: Global Carcinoembryonic Antigen (CEA) Market
The global Carcinoembryonic Antigen (CEA) market size is projected to reach US$ 2328 million by 2026, from US$ 1753.7 million in 2019, at a CAGR of 4.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Carcinoembryonic Antigen (CEA) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Carcinoembryonic Antigen (CEA) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Carcinoembryonic Antigen (CEA) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Carcinoembryonic Antigen (CEA) market.

Global Carcinoembryonic Antigen (CEA) Scope and Market Size
Carcinoembryonic Antigen (CEA) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Carcinoembryonic Antigen (CEA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f

Segment by Application
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche Diagnostics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CD66a
1.2.3 CD66b
1.2.4 CD66c
1.2.5 CD66d
1.2.6 CD66e
1.2.7 CD66f
1.3 Market by Application
1.3.1 Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Colorectal Cancer
1.3.3 Pancreatic Cancer
1.3.4 Ovarian Cancer
1.3.5 Breast Cancer
1.3.6 Thyroid Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Carcinoembryonic Antigen (CEA) Market Perspective (2016-2027)
2.2 Carcinoembryonic Antigen (CEA) Growth Trends by Regions
2.2.1 Carcinoembryonic Antigen (CEA) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Carcinoembryonic Antigen (CEA) Historic Market Share by Regions (2016-2021)
2.2.3 Carcinoembryonic Antigen (CEA) Forecasted Market Size by Regions (2022-2027)
2.3 Carcinoembryonic Antigen (CEA) Industry Dynamic
2.3.1 Carcinoembryonic Antigen (CEA) Market Trends
2.3.2 Carcinoembryonic Antigen (CEA) Market Drivers
2.3.3 Carcinoembryonic Antigen (CEA) Market Challenges
2.3.4 Carcinoembryonic Antigen (CEA) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue
3.1.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue (2016-2021)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2016-2021)
3.2 Global Carcinoembryonic Antigen (CEA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Carcinoembryonic Antigen (CEA) Revenue
3.4 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio
3.4.1 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen (CEA) Revenue in 2020
3.5 Carcinoembryonic Antigen (CEA) Key Players Head office and Area Served
3.6 Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
3.7 Date of Enter into Carcinoembryonic Antigen (CEA) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Carcinoembryonic Antigen (CEA) Breakdown Data by Type
4.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2016-2021)
4.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2022-2027)

5 Carcinoembryonic Antigen (CEA) Breakdown Data by Application
5.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Application (2016-2021)
5.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2016-2027)
6.2 North America Carcinoembryonic Antigen (CEA) Market Size by Type
6.2.1 North America Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021)
6.2.2 North America Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027)
6.2.3 North America Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2027)
6.3 North America Carcinoembryonic Antigen (CEA) Market Size by Application
6.3.1 North America Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021)
6.3.2 North America Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027)
6.3.3 North America Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2027)
6.4 North America Carcinoembryonic Antigen (CEA) Market Size by Country
6.4.1 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2016-2021)
6.4.2 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2016-2027)
7.2 Europe Carcinoembryonic Antigen (CEA) Market Size by Type
7.2.1 Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021)
7.2.2 Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027)
7.2.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2027)
7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Application
7.3.1 Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021)
7.3.2 Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027)
7.3.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2027)
7.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Country
7.4.1 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2016-2021)
7.4.2 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size (2016-2027)
8.2 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Type
8.2.1 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2027)
8.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Application
8.3.1 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2027)
8.4 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region
8.4.1 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Carcinoembryonic Antigen (CEA) Market Size (2016-2027)
9.2 Latin America Carcinoembryonic Antigen (CEA) Market Size by Type
9.2.1 Latin America Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021)
9.2.2 Latin America Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027)
9.2.3 Latin America Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2027)
9.3 Latin America Carcinoembryonic Antigen (CEA) Market Size by Application
9.3.1 Latin America Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021)
9.3.2 Latin America Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027)
9.3.3 Latin America Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2027)
9.4 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country
9.4.1 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2016-2021)
9.4.2 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size (2016-2027)
10.2 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Type
10.2.1 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2027)
10.3 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Application
10.3.1 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2027)
10.4 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country
10.4.1 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Diagnostics
11.2.1 Abbott Diagnostics Company Details
11.2.2 Abbott Diagnostics Business Overview
11.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2016-2021)
11.2.5 Abbott Diagnostics Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Introduction
11.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2016-2021)
11.3.5 Quest Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CD66a
Table 3. Key Players of CD66b
Table 4. Key Players of CD66c
Table 5. Key Players of CD66d
Table 6. Key Players of CD66e
Table 7. Key Players of CD66f
Table 8. Global Carcinoembryonic Antigen (CEA) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Carcinoembryonic Antigen (CEA) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Carcinoembryonic Antigen (CEA) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2016-2021)
Table 12. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2022-2027)
Table 14. Carcinoembryonic Antigen (CEA) Market Trends
Table 15. Carcinoembryonic Antigen (CEA) Market Drivers
Table 16. Carcinoembryonic Antigen (CEA) Market Challenges
Table 17. Carcinoembryonic Antigen (CEA) Market Restraints
Table 18. Global Carcinoembryonic Antigen (CEA) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Carcinoembryonic Antigen (CEA) Market Share by Players (2016-2021)
Table 20. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2020)
Table 21. Ranking of Global Top Carcinoembryonic Antigen (CEA) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Carcinoembryonic Antigen (CEA) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
Table 25. Date of Enter into Carcinoembryonic Antigen (CEA) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2016-2021)
Table 29. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Carcinoembryonic Antigen (CEA) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Application (2016-2021)
Table 33. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Carcinoembryonic Antigen (CEA) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Carcinoembryonic Antigen (CEA) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Roche Diagnostics Company Details
Table 66. Roche Diagnostics Business Overview
Table 67. Roche Diagnostics Carcinoembryonic Antigen (CEA) Product
Table 68. Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2016-2021) & (US$ Million)
Table 69. Roche Diagnostics Recent Development
Table 70. Abbott Diagnostics Company Details
Table 71. Abbott Diagnostics Business Overview
Table 72. Abbott Diagnostics Carcinoembryonic Antigen (CEA) Product
Table 73. Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2016-2021) & (US$ Million)
Table 74. Abbott Diagnostics Recent Development
Table 75. Quest Diagnostics Company Details
Table 76. Quest Diagnostics Business Overview
Table 77. Quest Diagnostics Carcinoembryonic Antigen (CEA) Product
Table 78. Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2016-2021) & (US$ Million)
Table 79. Quest Diagnostics Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carcinoembryonic Antigen (CEA) Market Share by Type: 2020 VS 2027
Figure 2. CD66a Features
Figure 3. CD66b Features
Figure 4. CD66c Features
Figure 5. CD66d Features
Figure 6. CD66e Features
Figure 7. CD66f Features
Figure 8. Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2020 VS 2027
Figure 9. Colorectal Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Ovarian Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Thyroid Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Carcinoembryonic Antigen (CEA) Report Years Considered
Figure 16. Global Carcinoembryonic Antigen (CEA) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Carcinoembryonic Antigen (CEA) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Carcinoembryonic Antigen (CEA) Market Share by Regions: 2020 VS 2027
Figure 19. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2022-2027)
Figure 20. Global Carcinoembryonic Antigen (CEA) Market Share by Players in 2020
Figure 21. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Carcinoembryonic Antigen (CEA) Revenue in 2020
Figure 23. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2016-2021)
Figure 24. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2022-2027)
Figure 25. North America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Carcinoembryonic Antigen (CEA) Market Share by Type (2016-2027)
Figure 27. North America Carcinoembryonic Antigen (CEA) Market Share by Application (2016-2027)
Figure 28. North America Carcinoembryonic Antigen (CEA) Market Share by Country (2016-2027)
Figure 29. United States Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Carcinoembryonic Antigen (CEA) Market Share by Type (2016-2027)
Figure 33. Europe Carcinoembryonic Antigen (CEA) Market Share by Application (2016-2027)
Figure 34. Europe Carcinoembryonic Antigen (CEA) Market Share by Country (2016-2027)
Figure 35. Germany Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Carcinoembryonic Antigen (CEA) Market Share by Region (2016-2027)
Figure 45. China Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Carcinoembryonic Antigen (CEA) Market Share by Type (2016-2027)
Figure 53. Latin America Carcinoembryonic Antigen (CEA) Market Share by Application (2016-2027)
Figure 54. Latin America Carcinoembryonic Antigen (CEA) Market Share by Country (2016-2027)
Figure 55. Mexico Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Carcinoembryonic Antigen (CEA) Market Share by Country (2016-2027)
Figure 61. Turkey Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Roche Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2016-2021)
Figure 65. Abbott Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2016-2021)
Figure 66. Quest Diagnostics Revenue Growth Rate in Carcinoembryonic Antigen (CEA) Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---